ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to combat cancer resistance. Established in 2014, ORIC aims to improve the efficacy and duration of existing cancer treatments through its proprietary resistance platform, which targets innate, acquired, and bypass resistance mechanisms. The company has advanced multiple product candidates, including ORIC-114 and ORIC-944, into clinical trials, demonstrating a strong commitment to addressing one of the most significant challenges in oncology. With a leadership team experienced in advancing oncology therapeutics from research to commercialization, ORIC is well-positioned in the biopharmaceutical landscape, having raised over $600 million in financing and established a robust pipeline of therapies.

United States

San Francisco, CA, USA

South San Francisco, CA, USA

ORIC Pharmaceuticals

Correlation Ventures

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Correlation Ventures Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Correlation Ventures network as they come up.

You can always update this information later.

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Correlation Ventures company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Companies you’ll love to work for